Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/4818

TDMS Study 88050-05 Pathology Tables

NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00
Route: GAVAGE                                                                                                     Time: 14:18:49

                                                  FINAL#1 2 YEAR CHRONIC RATS




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  126-98-7

       Lock Date:  05/05/99

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 


  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 4           10            9            7                                     
    Natural Death                                      7            6            6            7                                     
    Dosing Accident                                    1            1            1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                38           33           34           35                                     
    Natural Death                                                                             1                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (50)                                   
      Periesophageal Tissue, Hemorrhage                             1 (2%)       2 (4%)                                             
   Intestine Large, Rectum                            (50)         (50)         (50)         (50)                                   
      Parasite Metazoan                                2 (4%)       5 (10%)      5 (10%)      4 (8%)                                
   Intestine Large, Cecum                             (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                                            1 (2%)                                
   Intestine Small, Duodenum                          (50)         (50)         (50)         (50)                                   
      Fibrosis                                                                                1 (2%)                                
   Liver                                              (50)         (49)         (48)         (50)                                   
      Angiectasis                                                   1 (2%)       2 (4%)       1 (2%)                                
      Basophilic Focus                                43 (86%)     43 (88%)     35 (73%)     39 (78%)                               
      Clear Cell Focus                                 4 (8%)       2 (4%)       1 (2%)       3 (6%)                                
      Degeneration                                                               1 (2%)                                             
      Degeneration, Cystic                             1 (2%)                    1 (2%)                                             
      Eosinophilic Focus                                                         3 (6%)                                             
      Fatty Change                                    21 (42%)     13 (27%)     11 (23%)      7 (14%)                               
      Hepatodiaphragmatic Nodule                       9 (18%)      7 (14%)      8 (17%)     12 (24%)                               
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Chronic Active                    31 (62%)     27 (55%)     27 (56%)     27 (54%)                               
      Mixed Cell Focus                                 2 (4%)       7 (14%)      8 (17%)      5 (10%)                               
      Necrosis                                         2 (4%)       3 (6%)       1 (2%)                                             
      Thrombosis                                       2 (4%)                    3 (6%)                                             
      Vacuolization Cytoplasmic                        7 (14%)     14 (29%)     17 (35%)     30 (60%)                               
      Bile Duct, Hyperplasia                          14 (28%)      5 (10%)     13 (27%)      9 (18%)                               
   Mesentery                                          (7)          (2)          (8)          (4)                                    
      Fat, Inflammation, Chronic Active                5 (71%)      1 (50%)      2 (25%)      1 (25%)                               
      Fat, Necrosis                                    1 (14%)      1 (50%)      4 (50%)      2 (50%)                               
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Cytoplasmic Alteration                                                     1 (2%)                                             
      Hyperplasia                                      1 (2%)                    1 (2%)       1 (2%)                                
      Acinus, Atrophy                                  8 (16%)      4 (8%)       7 (14%)     10 (20%)                               
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Edema                                            1 (2%)       1 (2%)                                                          
      Hyperplasia                                      1 (2%)       1 (2%)                    1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)       2 (4%)       1 (2%)                                             
      Ulcer                                                                      1 (2%)                                             
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Erosion                                          1 (2%)       1 (2%)       2 (4%)       5 (10%)                               
      Mineralization                                                             1 (2%)                                             
      Ulcer                                            1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  24 (48%)     19 (38%)     16 (32%)     21 (42%)                               
      Fibrosis                                         1 (2%)                                                                       
      Thrombosis                                                    1 (2%)       2 (4%)       1 (2%)                                
      Epicardium, Inflammation, Chronic Active         1 (2%)                                                                       
      Pericardium, Inflammation, Chronic Active                                  1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Angiectasis                                     23 (46%)      6 (12%)     12 (24%)     19 (38%)                               
      Degeneration                                                               1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia                                      7 (14%)      6 (12%)     10 (20%)      7 (14%)                               
      Hypertrophy                                                   1 (2%)                                                          
      Necrosis                                                                                2 (4%)                                
      Thrombosis                                                                              1 (2%)                                
      Vacuolization Cytoplasmic                        4 (8%)       1 (2%)       2 (4%)       6 (12%)                               
      Capsule, Fibrosis                                1 (2%)                                                                       
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      2 (4%)                    3 (6%)       1 (2%)                                
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Angiectasis                                      6 (12%)      4 (8%)       3 (6%)       5 (10%)                               
      Cyst                                            19 (38%)     13 (26%)     14 (28%)     15 (30%)                               
      Hyperplasia                                     20 (40%)     23 (46%)     16 (32%)     16 (32%)                               
      Craniopharyngeal Duct, Hyperplasia               1 (2%)                                                                       
      Pars Nervosa, Hyperplasia                        1 (2%)                                                                       
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      C-Cell, Hyperplasia                             36 (72%)     25 (50%)     37 (74%)     32 (64%)                               
____________________________________________________________________________________________________________________________________

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (49)         (48)         (50)         (48)                                   
      Cyst                                             1 (2%)       4 (8%)       5 (10%)      1 (2%)                                
      Hyperplasia                                     10 (20%)      7 (15%)     10 (20%)      2 (4%)                                
      Inflammation, Chronic Active                     6 (12%)      2 (4%)       5 (10%)      8 (17%)                               
   Ovary                                              (50)         (50)         (50)         (50)                                   
      Atrophy                                                       1 (2%)                                                          
      Cyst                                                                       1 (2%)                                             
      Mineralization                                                             1 (2%)                                             
      Follicle, Cyst                                   3 (6%)       1 (2%)       1 (2%)       1 (2%)                                
      Periovarian Tissue, Cyst                         4 (8%)       3 (6%)       2 (4%)       3 (6%)                                
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Hydrometra                                       2 (4%)       2 (4%)       2 (4%)       2 (4%)                                
      Inflammation, Chronic Active                                  2 (4%)                                                          
      Cervix, Fibrosis                                 1 (2%)                    1 (2%)       1 (2%)                                
      Cervix, Inflammation, Chronic Active                                       3 (6%)       1 (2%)                                
      Endometrium, Hyperplasia, Cystic                 4 (8%)       1 (2%)       3 (6%)       3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)       1 (2%)                    1 (2%)                                
      Hyperplasia                                     12 (24%)     11 (22%)     12 (24%)     25 (50%)                               
      Myelofibrosis                                    1 (2%)                                                                       
   Lymph Node                                         (6)          (1)          (5)          (1)                                    
      Mediastinal, Hyperplasia                                                   1 (20%)                                            
   Lymph Node, Mandibular                             (50)         (49)         (50)         (50)                                   
      Ectasia                                          1 (2%)       1 (2%)                    1 (2%)                                
      Hyperplasia                                                                1 (2%)                                             
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (50)                                   
      Ectasia                                                       1 (2%)                    1 (2%)                                
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Accessory Spleen                                                                        1 (2%)                                
      Fibrosis                                         1 (2%)       1 (2%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                 1 (2%)       8 (16%)      7 (14%)      5 (10%)                               
      Capsule, Necrosis                                                                       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (50)                                   
      Galactocele                                     13 (26%)      9 (18%)      9 (18%)      9 (18%)                               
      Hyperplasia                                      8 (16%)     11 (22%)      9 (18%)      6 (12%)                               
      Inflammation, Chronic Active                                  1 (2%)                                                          
   Skin                                               (50)         (50)         (50)         (50)                                   
      Parakeratosis                                                 1 (2%)                                                          
      Ulcer                                                         1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Osteosclerosis                                   1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Congestion                                                                 1 (2%)                                             
      Hemorrhage                                                    1 (2%)       2 (4%)                                             
      Inflammation, Chronic Active                     5 (10%)      4 (8%)       4 (8%)       4 (8%)                                
      Necrosis                                                                   1 (2%)                                             
      Pigmentation                                                               1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 6 (12%)      3 (6%)       4 (8%)       6 (12%)                               
      Mediastinum, Inflammation                                                  1 (2%)                                             
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation                                                  1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)                    2 (4%)       1 (2%)                                
      Thrombosis                                                    3 (6%)       1 (2%)       2 (4%)                                
      Olfactory Epithelium, Atrophy                                              1 (2%)      19 (38%)                               
      Olfactory Epithelium, Metaplasia                                                       47 (94%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (4)          (1)          (3)          (1)                                    
      Cataract                                         4 (100%)     1 (100%)     3 (100%)     1 (100%)                              
      Lens, Mineralization                             3 (75%)                   2 (67%)                                            
      Retina, Degeneration                             3 (75%)      1 (100%)     3 (100%)     1 (100%)                              
   Zymbal's Gland                                                               (1)                                                 

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
SPECIAL SENSES SYSTEM - CONT                                                                                                        
      Inflammation, Chronic Active                                               1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Accumulation, Hyaline Droplet                    2 (4%)                    1 (2%)                                             
      Congestion                                                    1 (2%)                                                          
      Hydronephrosis                                                                          1 (2%)                                
      Inflammation, Chronic Active                     3 (6%)       9 (18%)      5 (10%)      3 (6%)                                
      Necrosis                                         1 (2%)                                                                       
      Nephropathy                                     29 (58%)     27 (54%)     29 (58%)     25 (50%)                               
      Pigmentation                                     3 (6%)       3 (6%)       2 (4%)                                             
      Renal Tubule, Hyperplasia                                     1 (2%)                                                          
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       1 (2%)                                             
      Transitional Epithelium, Hyperplasia                                                    1 (2%)                                
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 


  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                     12            3            6            6                                     
    Moribund Sacrifice                                13           13            9           12                                     
    Dosing Accident                                                                           1                                     
  Survivors                                                                                                                         
    Natural Death                                                                1                                                  
    Terminal Sacrifice                                25           34           34           31                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                               1 (2%)                                             
      Parasite Metazoan                                             1 (2%)       1 (2%)                                             
      Pigmentation                                                               1 (2%)                                             
   Intestine Large, Rectum                            (50)         (50)         (50)         (50)                                   
      Parasite Metazoan                               10 (20%)      8 (16%)      7 (14%)      5 (10%)                               
   Intestine Large, Cecum                             (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Epithelium, Atrophy                                                        1 (2%)                                             
   Intestine Small, Duodenum                          (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                  1 (2%)       1 (2%)                                             
      Parasite Metazoan                                             1 (2%)                                                          
   Intestine Small, Jejunum                           (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                               2 (4%)                                             
   Intestine Small, Ileum                             (50)         (50)         (49)         (50)                                   
      Inflammation, Chronic Active                                               2 (4%)                                             
      Parasite Metazoan                                1 (2%)                                                                       
   Liver                                              (50)         (50)         (50)         (49)                                   
      Angiectasis                                      2 (4%)       4 (8%)       7 (14%)      4 (8%)                                
      Basophilic Focus                                26 (52%)     33 (66%)     35 (70%)     13 (27%)                               
      Clear Cell Focus                                 8 (16%)     16 (32%)     16 (32%)      4 (8%)                                
      Congestion                                       1 (2%)                    1 (2%)                                             
      Cyst                                                                                    1 (2%)                                
      Degeneration, Cystic                             3 (6%)       7 (14%)      5 (10%)      6 (12%)                               
      Eosinophilic Focus                              10 (20%)      8 (16%)      9 (18%)      7 (14%)                               
      Fatty Change                                    23 (46%)     18 (36%)     21 (42%)      9 (18%)                               
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hepatodiaphragmatic Nodule                       8 (16%)      5 (10%)      9 (18%)      6 (12%)                               
      Inclusion Body Intracytoplasmic                                                         1 (2%)                                
      Inflammation, Chronic Active                    16 (32%)     21 (42%)     29 (58%)     10 (20%)                               
      Mixed Cell Focus                                16 (32%)     23 (46%)     22 (44%)     10 (20%)                               
      Necrosis                                         4 (8%)       1 (2%)                    3 (6%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Thrombosis                                                    1 (2%)                                                          
      Vacuolization Cytoplasmic                       14 (28%)     18 (36%)     23 (46%)     28 (57%)                               
      Bile Duct, Fibrosis                              1 (2%)                                                                       
      Bile Duct, Hyperplasia                          42 (84%)     48 (96%)     48 (96%)     36 (73%)                               
   Mesentery                                          (13)         (13)         (11)         (12)                                   
      Artery, Inflammation, Chronic Active             1 (8%)                                                                       
      Fat, Inflammation, Chronic Active                8 (62%)     12 (92%)     11 (100%)     9 (75%)                               
      Fat, Mineralization                                           1 (8%)                                                          
      Fat, Necrosis                                    1 (8%)       1 (8%)                    1 (8%)                                
   Pancreas                                           (50)         (49)         (50)         (50)                                   
      Cytoplasmic Alteration                           2 (4%)                    3 (6%)                                             
      Fibrosis                                                      1 (2%)                                                          
      Hyperplasia                                      4 (8%)      10 (20%)     11 (22%)     12 (24%)                               
      Acinus, Atrophy                                 10 (20%)     13 (27%)     12 (24%)     14 (28%)                               
      Artery, Inflammation, Chronic Active             1 (2%)                    1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Erosion                                          1 (2%)                                                                       
      Hyperkeratosis                                   1 (2%)                                                                       
      Hyperplasia                                      3 (6%)       3 (6%)                    1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                                          
      Perforation                                      1 (2%)                                                                       
      Ulcer                                            2 (4%)       2 (4%)       2 (4%)                                             
      Epithelium, Hyperplasia                                                    1 (2%)                                             
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Erosion                                          3 (6%)                    5 (10%)      2 (4%)                                
      Mineralization                                   1 (2%)                                                                       
      Ulcer                                            4 (8%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (49)         (50)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                                          
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  43 (86%)     48 (96%)     41 (82%)     46 (92%)                               
      Fibrosis                                         1 (2%)                    1 (2%)                                             
      Thrombosis                                       3 (6%)       1 (2%)       1 (2%)       3 (6%)                                
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
      Endocardium, Hyperplasia                                                                1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Angiectasis                                      5 (10%)      3 (6%)      12 (24%)      9 (18%)                               
      Atrophy                                          1 (2%)                    1 (2%)                                             
      Degeneration, Cystic                                                       1 (2%)                                             

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hematopoietic Cell Proliferation                                                        2 (4%)                                
      Hyperplasia                                      9 (18%)     10 (20%)     11 (22%)      8 (16%)                               
      Necrosis                                                                   1 (2%)                                             
      Pigmentation                                                               1 (2%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Vacuolization Cytoplasmic                        8 (16%)      3 (6%)       3 (6%)       5 (10%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     11 (22%)      5 (10%)      7 (14%)      7 (14%)                               
      Mineralization                                                1 (2%)                                                          
   Islets, Pancreatic                                 (50)         (50)         (50)         (50)                                   
      Hyperplasia                                      1 (2%)       1 (2%)                    1 (2%)                                
   Parathyroid Gland                                  (46)         (46)         (50)         (50)                                   
      Fibrosis                                                      1 (2%)                                                          
      Hyperplasia, Focal                                                         1 (2%)                                             
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Angiectasis                                      2 (4%)                    3 (6%)                                             
      Atrophy                                          1 (2%)                    1 (2%)                                             
      Cyst                                             5 (10%)      5 (10%)      7 (14%)      1 (2%)                                
      Hyperplasia                                     13 (26%)     17 (34%)     16 (32%)     10 (20%)                               
      Craniopharyngeal Duct, Hyperplasia                            1 (2%)                                                          
   Thyroid Gland                                      (50)         (50)         (50)         (50)                                   
      C-Cell, Hyperplasia                             23 (46%)     29 (58%)     35 (70%)     29 (58%)                               
      Follicle, Cyst                                   1 (2%)                                                                       
      Follicular Cell, Hyperplasia                     3 (6%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
   Preputial Gland                                    (50)         (50)         (50)         (49)                                   
      Hyperplasia                                      1 (2%)       1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                    41 (82%)     45 (90%)     46 (92%)     45 (92%)                               
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Atrophy                                                       1 (2%)       1 (2%)       3 (6%)                                
      Cyst                                             1 (2%)                                                                       
      Hyperplasia                                                                5 (10%)      2 (4%)                                
      Inflammation                                    25 (50%)     25 (50%)     17 (34%)     24 (48%)                               
   Seminal Vesicle                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)       2 (4%)       1 (2%)       4 (8%)                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Testes                                             (50)         (50)         (50)         (50)                                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Atrophy                                          6 (12%)      6 (12%)      5 (10%)      2 (4%)                                
      Mineralization                                   1 (2%)                                                                       
      Necrosis                                                                   1 (2%)                                             
      Interstitial Cell, Hyperplasia                   9 (18%)      6 (12%)      4 (8%)       3 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     17 (34%)     14 (28%)     19 (38%)     20 (40%)                               
      Myelofibrosis                                    1 (2%)                                                                       
   Lymph Node                                         (7)          (3)          (3)          (4)                                    
      Mediastinal, Congestion                          1 (14%)                                                                      
      Mediastinal, Ectasia                                                       1 (33%)                                            
      Mediastinal, Inflammation, Chronic Active                                  1 (33%)                                            
      Renal, Congestion                                                          1 (33%)                                            
      Renal, Ectasia                                                1 (33%)                                                         
      Renal, Inflammation, Chronic Active                                        1 (33%)                                            
   Lymph Node, Mandibular                             (49)         (50)         (49)         (49)                                   
      Ectasia                                          1 (2%)       4 (8%)       1 (2%)       4 (8%)                                
      Hyperplasia                                      1 (2%)                                                                       
      Hyperplasia, Plasma Cell                         2 (4%)       1 (2%)                    2 (4%)                                
   Lymph Node, Mesenteric                             (50)         (50)         (50)         (50)                                   
      Congestion                                       1 (2%)                                                                       
      Ectasia                                          2 (4%)       3 (6%)       1 (2%)       4 (8%)                                
      Inflammation, Chronic Active                                               2 (4%)                                             
   Spleen                                             (50)         (50)         (50)         (49)                                   
      Accessory Spleen                                                           1 (2%)                                             
      Angiectasis                                                   1 (2%)                                                          
      Fibrosis                                         6 (12%)      4 (8%)       4 (8%)       4 (8%)                                
      Hematopoietic Cell Proliferation                 4 (8%)       3 (6%)       3 (6%)       7 (14%)                               
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia, Histiocytic                                                                1 (2%)                                
      Necrosis                                         1 (2%)                    1 (2%)       1 (2%)                                
      Capsule, Fibrosis                                             1 (2%)                                                          
      Capsule, Inflammation, Chronic Active                                                   1 (2%)                                
   Thymus                                             (49)         (47)         (45)         (50)                                   
      Cyst                                             1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (46)         (50)         (49)         (49)                                   
      Galactocele                                                   5 (10%)                   1 (2%)                                
      Hyperplasia                                      2 (4%)       3 (6%)       4 (8%)       4 (8%)                                
   Skin                                               (49)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                        1 (2%)                                                                       

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Hyperkeratosis                                                             2 (4%)       1 (2%)                                
      Hyperplasia                                                                2 (4%)                                             
      Inflammation, Chronic Active                                               1 (2%)       1 (2%)                                
      Parakeratosis                                                              1 (2%)                                             
      Subcutaneous Tissue, Fibrosis                                              1 (2%)                                             
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hydrocephalus                                                                           1 (2%)                                
      Necrosis                                         2 (4%)                    1 (2%)                                             
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
   Spinal Cord                                        (1)          (2)          (1)          (1)                                    
      Hemorrhage                                                                              1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Congestion                                                    2 (4%)       1 (2%)                                             
      Edema                                                         1 (2%)                                                          
      Hemorrhage                                       4 (8%)                    2 (4%)                                             
      Inflammation, Chronic Active                     3 (6%)       3 (6%)       4 (8%)       6 (12%)                               
      Leukocytosis                                                               1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 3 (6%)       8 (16%)      6 (12%)      4 (8%)                                
   Nose                                               (50)         (50)         (49)         (50)                                   
      Abscess                                                                                 1 (2%)                                
      Inflammation, Chronic Active                     6 (12%)      7 (14%)      6 (12%)      6 (12%)                               
      Thrombosis                                       2 (4%)       1 (2%)                    1 (2%)                                
      Olfactory Epithelium, Atrophy                                                          48 (96%)                               
      Olfactory Epithelium, Metaplasia                                                       47 (94%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
NTP Experiment-Test: 88050-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                         METHACRYLONITRILE                                     Date: 02/24/00  
Route: GAVAGE                                                                                                     Time: 14:18:49  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     0 MG/KG      3 MG/KG      10 MG/KG     30 MG/KG                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (1)                                                              
      Cataract                                                      1 (100%)                                                        
      Degeneration                                     1 (100%)                                                                     
      Lens, Mineralization                                          1 (100%)                                                        
      Retina, Atrophy                                               1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                                          2 (4%)       1 (2%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Infarct                                          1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                    13 (26%)     25 (50%)     22 (44%)     18 (36%)                               
      Mineralization                                                                          1 (2%)                                
      Nephropathy                                     44 (88%)     48 (96%)     46 (92%)     47 (94%)                               
      Pigmentation                                                  2 (4%)       3 (6%)       1 (2%)                                
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Inflammation, Chronic Active                                  1 (2%)                                                          
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------